Wash & Sterilisation Specialist in Product Supply, Novo
Nordisk A/S.
Not considered independent under the Danish Corporate
Governance Recommendations.
Employed in Novo Nordisk since
2001.
Employee-elected member of the Board of Directors since
March 2018. Most recently elected in 2022 for a term of four years
(term expires in March 2026).
Member of the Audit Committee
since March 2022. The Board has assessed that Ms Jensen relies on an
exemption to the independence requirements in the US Securities
Exchange Act.
2010: Graduate Programme (HD) in Business Administration
(Strategic management and business development), Copenhagen Business
School, Denmark.
2001: MSc in Biotechnology, Aalborg
University, Denmark.